Apothekary Inc. – Trademark Portfolio
Entity Type: 03
Apothekary Inc. holds 29 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 25 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 14 trademarks are registered. Notable registered marks include A, BLUE BURN, YOU DEW YOU, APOTHÉKARY A, and CLAIM TO FLAME. The owner is based in Falls Church, VA.
2824 Fallfax Drive
Falls Church, VA 22042
Showing of trademarks Trademarks
Trademark Classifications
Apothekary Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Apothekary Inc. have?
Apothekary Inc. has 29 U.S. trademarks filed with the USPTO. Of these, 14 registered, 15 abandoned.
What trademark classes does Apothekary Inc. file in?
Apothekary Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Apothekary Inc.'s most well-known trademarks?
Apothekary Inc.'s registered trademark portfolio includes well-known marks such as A, BLUE BURN, YOU DEW YOU, APOTHÉKARY A, and CLAIM TO FLAME. These are among 14 currently registered trademarks in the portfolio.
What is Apothekary Inc.'s trademark registration success rate?
Apothekary Inc. has a 48% trademark registration rate, with 14 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.